pre-miRNA Information | |
---|---|
pre-miRNA | hsa-mir-4330 |
Genomic Coordinates | chrX: 151168222 - 151168326 |
Description | Homo sapiens miR-4330 stem-loop |
Comment | None |
RNA Secondary Structure |
Mature miRNA Information | |||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mature miRNA | hsa-miR-4330 | ||||||||||||
Sequence | 77| CCUCAGAUCAGAGCCUUGC |95 | ||||||||||||
Evidence | Experimental | ||||||||||||
Experiments | SOLiD | ||||||||||||
SNPs in miRNA |
|
||||||||||||
Putative Targets |
miRNA Expression profile | |
---|---|
miRNAs in Extracellular Vesicles |
|
Circulating MicroRNA Expression Profiling |
Gene Information | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Gene Symbol | EDEM1 | ||||||||||||||||||||
Synonyms | EDEM | ||||||||||||||||||||
Description | ER degradation enhancing alpha-mannosidase like protein 1 | ||||||||||||||||||||
Transcript | NM_014674 | ||||||||||||||||||||
Expression | |||||||||||||||||||||
Putative miRNA Targets on EDEM1 | |||||||||||||||||||||
3'UTR of EDEM1 (miRNA target sites are highlighted) |
>EDEM1|NM_014674|3'UTR 1 TCTGCTCTCTGTGAGGCCTCATCTTGAACCAGACCTTAACGACCAAACCCAGACCATGCCAAAGTCCAGTCTGAAATGAA 81 AGGGGACAGAAGTCTTGCTGTCCATGGTGGTGTAGGAATTTCTGTGCAACACCTCACCACGTCTGGTTAATCCTTGCACA 161 CTTCAGTGTTTCTCTCCTGTTCAATAAAATGCCCTGTTAAGGATATAATTTGAAGTGAGAAGATACATGGAAATTGCCCT 241 CTTATGACATGTTGATGTTATAAGCACAATAGATGGGGCATCTTTGGATTGATGTTCACAGCTTTATACTTCAGAACCTA 321 AGTCTCTTCACTTTGCTGGCACCTGCTATACTGGAGTATTGCTATGTCTTTAAAAAATTTTTTTTATTATATTTTATTTT 401 TTTGAGACAGGGTCTTGATATTTTTTTGGGACAGGGTTACCTGGGCTCAAGTGATCCTTCTGCCTCAGCCTCCCGAGTAG 481 CTGGGATTACAGGTGAGCACCACTGTACCTGGCTAGCTACTTCTTTGTTAGAGGATTGAGAATGAAATTTCTGCAAAAGG 561 GCCCATGGTTCATTTGGTATCCCTATTTAATTGCATTGAAAATGTCATCCTTTCTGTTGTTAGATAATTGGGGTCTTCCC 641 CTGATATCCAACCGTGATTTTGGATCACATGGGAGAAAAAGTCATCCAGTTTTTCATGTTTGCCTCAAGTAATCTTTACA 721 GTGTTACAAATTATTTGCTTAAGAAGAATGGTCTTAACCAGAATTCTTAACAGATAGTCTCTTAGGTTATTATGTTATGG 801 TCTAAGAGGTTAACTGACATCTTTTGGGTGGTATTTTGCATTTTGAATATGAACTTACCTGAGGAACTCCCATAGTTCCA 881 GAATCAGGTGCCTTTTAGGGAGAGAACAATACCTAAGATTGTCTGAGCTTCCATCTTTCTCATATTTCCTAAGCAAGGAT 961 TCTCACTTCTGACCATATTTGGGTTAGAGTTCTGTTTTGTTTCTGTTTTCTGTGTCTAGTGCCAATTAGCTAAATCAGGG 1041 AGAAAGAAATGATCACATGACTTTTAGCATCCTTGAGCCATTTCTCTGTGTAATACAGGCTTTAGATTAGTGCCTTATAT 1121 TGGTTTTGGTTTGGGGCACTGGATGTCGCAGCTACTGCTATGGTTTCAGGAGGCCTGTTTAGCCACATGGTGAGACCGTG 1201 GTGAAAGGGGGATGGAAATTGCTTGGCCAGTCTTTGCCTTTCATCCTGTAAAAGTAAGCATGTAGAAGGAGGAAGTTGTG 1281 CTAAAATGCCTTTGTTTTTTTGTTATTATTTTCTTAGCCAGAACATCTCTCTTTGAACTCACACTGATACACACCTGCTA 1361 CTCTTACACAGTGCAGCAGGGTTGACTCTTAGTCTGGCTTCCATGAAGCGTCATGGGTGGAAACGCATTCTAGTAAAAAA 1441 GGTAGGAAATCCCTAAAACTTCCAGCCTCACATAGCACGGTTCTCACCTGTCACTGTTTTCCCACCTCTAAGGATTTCAT 1521 GTACATCTTTTCAAAGCTAGAAATAAGCACTGTCTAAGTTTATGTTGCATTTTTAGTCAAAAGGGAGAAATCTTATTCCT 1601 TCTTGAAAATTTTAAGTGTTATGGTTTTATATAGTTCAGTTCTTTGAGATTTTTGAAAAGAGTATTTTCAGTAATAAACG 1681 TGCCATCTCTATCTCTTAAACATTTATTACAACAATTGTTTTAAAATAGAAAAAATAAAATGCTTCTATTTTACCTTTTT 1761 TCATTTCAGAAGCATTATTCTGTTTATTAACAGTGTCCCATCTACTGAATAGAAAACTTTGAGAATAATATATATATATA 1841 TTTTAAATGTTTTCACTGACTCATTGAAAATGTTAATTACACACACATGCATGCATGCACACACGAGCATACTTGTACCT 1921 TTGTCTCTGGGCAAACAGGTGGGACTGTTAGTGACCCATTTGGGAAAATAGAGCATCTCAGAGAAGGAGGTGAGTTCTTC 2001 CTGCCTGTGATTTCTCTTGGCGCTCCCCTCCTCTCCCGCTCTGGCTTCTGTGGCGGCAGTGGTGGGTAAGCACTCCAGTG 2081 TTCTCTTAATGAGGCACTTTGCCTGTCACTCGAGCAAGCCTGGGTGTTCCTTCCTCCTCATGCTCCTGGAATAGGGAATA 2161 GGGATCTCATGCTTGCAAACTACACAATGCTGCAGGTGCTTCCCAGGGGCCACAGGCTGTCAGGAAACGTGTTTTATGTT 2241 AAGTCACAAACCCACTTGACTTCTGGGTACTGGAATTAATACCAGTGGGTGAGACTGAGGGTGAGTGAGTTAGTACATAT 2321 TAATCCTGGTTGTTGAGCTTCCAGACTACCCCGTCCAAAGTTTGATGCTATGTAGTCAGTGGTTTGTGGGGCTGGATGCC 2401 AGAAGGTTCTTTGAGCCAGTTTCAAAGGTTACTTGTTTTTTTTTTTTTTTTTTAAAGTCAGAATGTTAACAGCTGTGATA 2481 TATCCTGCAGGGCTTTTGCAGTTTCTTCTGTTCTGTGTTCTGAAATACTGGGTAGAGAATGGCTGAGGAGGAGATTACCA 2561 GAGAAGTTGCTTTGCTCAGTGCTTTGCCCCAGGATTGCCTCAAATCTGAGTGGACTTCATCCTTTGCGGCGGCTCTGAGC 2641 CTGGCCCATCTTCCTATTCCCACGTGTAGCTAGTGTCTAGTGTCAGCTTTGCTCAGTGTGGTGGAAACATTTTGCAGAAC 2721 TGTTGTAGAAAGCTGCCTTATAGTTGGCTTGACAAAGCATAATTCTCTCATAACAAACTTTCAAATCATTACAGTAGCTT 2801 AGCTACTTTAGTTGATGTGACCGAGGAATCCCTTCTAGAATCATAGGTGGCAAGGGAGGGTTTGCTAGCTCTCCATTTGC 2881 ACTGGCCATTGTGAAAAACCAGCTTCTGTATTCAAATCTTTCCTTCATTTTTTTAAATTTTTTTTTTGGCAGCGCTTGTG 2961 CTGGAACTTACTCATTGTAACTGAATCCTCAGGGCTTTTCTTGTTTTAGATCATGGACTGTGCACGTGACACTTAAATAA 3041 TTTTCTATGTATTTAAAGAAAAATGCACCAGGATGGTGTCTGTGCACGTGACTATTAGAGGAGCGTCTGTAGAAGTACCT 3121 GGTTTGGTCAGTGCAGTTGTGCAATCTGAGGGCCTTGTTTCCTCCTCCCCTTTCCCCTTCTCCCCACCAAAGGAAAATAT 3201 CCCTCTTAATGATTTCGTAGTTCAGTTTACTGAATGATTACCACCTGTAATTCCTCTTTGGATTGTGTAGACTCAACATG 3281 AGACATTCCTTTCTGCTTTCTGGAGGGCACCAGGGGCCTTTCTCTTTGATAAATTTTTTTTGTCTGTTGACAAAAACAAA 3361 AATCTTTTTTCAAATGTAGTGCTGGTGAAAAGGTAGGGCTGAGTGATTACCTTAGCCACAGGGTGGCTGAGCAGGAACTT 3441 TAGAAGAAAATCCTGAGCTTTCCTGTCCATTCCCAGCATCCAGCTCCTATTCTAGTGCCTCTTCCCTGCAGGGCAGGGAC 3521 CCCTTGGGAAATCGAGGAGGTGGGACGGGCTGGGCCCTGTGTCCCAGGTTTCACAGGGCTCAGGGTTATGCTCCCGCTTG 3601 AATCTGGACGTGAATCTGGTAAAAATATCAAGTACCTGTGGAACTCCCTGATTCTATACCCTCTTCCTTCTTTCTGCAAG 3681 GCAGAGGAATAATATTTTTAAAGGTTATTTTGTTTTAGTTTTAAATAGCAAAACACAAGCTGCATTTTTATTTATTTTGC 3761 ATAAGAAAGGTAAATCTTTTTACAAAAAAAAGTATAGAGTTGGAAACTCTGGGAAAACTTACGGAAATACACAAATGCTT 3841 CTCTGTAATGTGCAATATGCTTTGCAACTGTAGATGATATTTTATGTTTAATCTGTAAATAAGAAATGTATTTAAATTAA 3921 AAGGGATCTTTTTGTAAAAGGACCAAATGTTCTTTTATAAATGTAATAAGGAATATCTTGCTCTTTAAAATTTATTAGGA 4001 TTTTTATGAGTAATTTTTATTAAAAGATTTCTTTTTTTGAGTTGTCAAAAAAAAAA Target sites
Provided by authors
Predicted by miRanda
DRVs
SNPs
DRVs & SNPs
|
||||||||||||||||||||
miRNA-target interactions (Predicted by miRanda) |
|
||||||||||||||||||||
DRVs in gene 3'UTRs | |||||||||||||||||||||
SNPs in gene 3'UTRs |
Experimental Support 1 for Functional miRNA-Target Interaction | |||||||
---|---|---|---|---|---|---|---|
miRNA:Target | ---- | ||||||
Validation Method |
|
||||||
Conditions | HEK293 | ||||||
Disease | 9695.0 | ||||||
Location of target site | 3'UTR | ||||||
Tools used in this research | TargetScan , miRTarCLIP , Piranha | ||||||
Original Description (Extracted from the article) |
...
"PAR-CLIP data was present in GSM714644. RNA binding protein: AGO2. Condition:completeT1
... - Kishore S; Jaskiewicz L; Burger L; Hausser et al., 2011, Nature methods. |
||||||
miRNA-target interactions (Provided by authors) |
|
||||||
Article |
- Kishore S; Jaskiewicz L; Burger L; Hausser et al. - Nature methods, 2011
Cross-linking and immunoprecipitation (CLIP) is increasingly used to map transcriptome-wide binding sites of RNA-binding proteins. We developed a method for CLIP data analysis, and applied it to compare CLIP with photoactivatable ribonucleoside-enhanced CLIP (PAR-CLIP) and to uncover how differences in cross-linking and ribonuclease digestion affect the identified sites. We found only small differences in accuracies of these methods in identifying binding sites of HuR, which binds low-complexity sequences, and Argonaute 2, which has a complex binding specificity. We found that cross-link-induced mutations led to single-nucleotide resolution for both PAR-CLIP and CLIP. Our results confirm the expectation from original CLIP publications that RNA-binding proteins do not protect their binding sites sufficiently under the denaturing conditions used during the CLIP procedure, and we show that extensive digestion with sequence-specific RNases strongly biases the recovered binding sites. This bias can be substantially reduced by milder nuclease digestion conditions.
LinkOut: [PMID: 21572407]
|
Experimental Support 2 for Functional miRNA-Target Interaction | |||||||
---|---|---|---|---|---|---|---|
miRNA:Target | ---- | ||||||
Validation Method |
|
||||||
Conditions | hESCs (WA-09) | ||||||
Disease | 9695.0 | ||||||
Location of target site | 3'UTR | ||||||
Tools used in this research | TargetScan , miRTarCLIP , Piranha | ||||||
Original Description (Extracted from the article) |
...
"PAR-CLIP data was present in SRR359787. RNA binding protein: AGO2. Condition:4-thiouridine
... - Lipchina I; Elkabetz Y; Hafner M; Sheridan et al., 2011, Genes & development. |
||||||
miRNA-target interactions (Provided by authors) |
|
||||||
Article |
- Lipchina I; Elkabetz Y; Hafner M; Sheridan et al. - Genes & development, 2011
MicroRNAs are important regulators in many cellular processes, including stem cell self-renewal. Recent studies demonstrated their function as pluripotency factors with the capacity for somatic cell reprogramming. However, their role in human embryonic stem (ES) cells (hESCs) remains poorly understood, partially due to the lack of genome-wide strategies to identify their targets. Here, we performed comprehensive microRNA profiling in hESCs and in purified neural and mesenchymal derivatives. Using a combination of AGO cross-linking and microRNA perturbation experiments, together with computational prediction, we identified the targets of the miR-302/367 cluster, the most abundant microRNAs in hESCs. Functional studies identified novel roles of miR-302/367 in maintaining pluripotency and regulating hESC differentiation. We show that in addition to its role in TGF-beta signaling, miR-302/367 promotes bone morphogenetic protein (BMP) signaling by targeting BMP inhibitors TOB2, DAZAP2, and SLAIN1. This study broadens our understanding of microRNA function in hESCs and is a valuable resource for future studies in this area.
LinkOut: [PMID: 22012620]
|
Experimental Support 3 for Functional miRNA-Target Interaction | |
---|---|
miRNA:Target | ---- |
Validation Method |
|
Conditions | TZM-bl |
Location of target site | 3'UTR |
Tools used in this research | TargetScan , miRTarCLIP , Piranha |
Original Description (Extracted from the article) |
...
PAR-CLIP data was present in GSM1462574. RNA binding protein: AGO2. Condition:TZM-bl ami BaL
... - Whisnant AW; Bogerd HP; Flores O; Ho P; et al., 2013, mBio. |
Article |
- Whisnant AW; Bogerd HP; Flores O; Ho P; et al. - mBio, 2013
UNLABELLED: The question of how HIV-1 interfaces with cellular microRNA (miRNA) biogenesis and effector mechanisms has been highly controversial. Here, we first used deep sequencing of small RNAs present in two different infected cell lines (TZM-bl and C8166) and two types of primary human cells (CD4(+) peripheral blood mononuclear cells [PBMCs] and macrophages) to unequivocally demonstrate that HIV-1 does not encode any viral miRNAs. Perhaps surprisingly, we also observed that infection of T cells by HIV-1 has only a modest effect on the expression of cellular miRNAs at early times after infection. Comprehensive analysis of miRNA binding to the HIV-1 genome using the photoactivatable ribonucleoside-induced cross-linking and immunoprecipitation (PAR-CLIP) technique revealed several binding sites for cellular miRNAs, a subset of which were shown to be capable of mediating miRNA-mediated repression of gene expression. However, the main finding from this analysis is that HIV-1 transcripts are largely refractory to miRNA binding, most probably due to extensive viral RNA secondary structure. Together, these data demonstrate that HIV-1 neither encodes viral miRNAs nor strongly influences cellular miRNA expression, at least early after infection, and imply that HIV-1 transcripts have evolved to avoid inhibition by preexisting cellular miRNAs by adopting extensive RNA secondary structures that occlude most potential miRNA binding sites. IMPORTANCE: MicroRNAs (miRNAs) are a ubiquitous class of small regulatory RNAs that serve as posttranscriptional regulators of gene expression. Previous work has suggested that HIV-1 might subvert the function of the cellular miRNA machinery by expressing viral miRNAs or by dramatically altering the level of cellular miRNA expression. Using very sensitive approaches, we now demonstrate that neither of these ideas is in fact correct. Moreover, HIV-1 transcripts appear to largely avoid regulation by cellular miRNAs by adopting an extensive RNA secondary structure that occludes the ability of cellular miRNAs to interact with viral mRNAs. Together, these data suggest that HIV-1, rather than seeking to control miRNA function in infected cells, has instead evolved a mechanism to become largely invisible to cellular miRNA effector mechanisms.
LinkOut: [PMID: 23592263]
|
CLIP-seq Support 1 for dataset GSM4903833 | |
---|---|
Method / RBP | HITS-CLIP / AGO |
Cell line / Condition | Dermal fibroblasts / CTL_TD_21_a |
Location of target site | NM_014674 | 3UTR | AAUGGCUGAGGAGGAGAUUACCAGAGAAGUUGCUUUGCUCAGUGCUUUGCCCCAGGAUUGCCUCAAAUCUGAGUGGACUUCAUCCUUUGCGGCGGCUCUGAGCCUGGCCCAUCUUCCUAUUCCCACGUGUAGCUAGUGUCUA |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Accession Series | GSE161239 |
CLIP-seq Viewer | Link |
CLIP-seq Support 2 for dataset GSM4903834 | |
---|---|
Method / RBP | HITS-CLIP / AGO |
Cell line / Condition | Dermal fibroblasts / CTL_TD_21_b |
Location of target site | NM_014674 | 3UTR | AUUACCAGAGAAGUUGCUUUGCUCAGUGCUUUGCCCCAGGAUUGCCUCAAAUCUGAGUGGACUUCAUCCUUUGCGGCGGCUCUGAGCCUGGCCCAUCUUCCUAUUCCCACGUGUAGCUAGUGUCUA |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Accession Series | GSE161239 |
CLIP-seq Viewer | Link |
CLIP-seq Support 3 for dataset GSM4903835 | |
---|---|
Method / RBP | HITS-CLIP / AGO |
Cell line / Condition | Dermal fibroblasts / CTL_TD_21_c |
Location of target site | NM_014674 | 3UTR | GGAGAUUACCAGAGAAGUUGCUUUGCUCAGUGCUUUGCCCCAGGAUUGCCUCAAAUCUGAGUGGACUUCAUCCUUUGCGGCGGCUCUGAGCCUGGCCCAUCUUCCUAUUCCCACGUGUAGCUAGUGUCUA |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Accession Series | GSE161239 |
CLIP-seq Viewer | Link |
CLIP-seq Support 4 for dataset GSM4903836 | |
---|---|
Method / RBP | HITS-CLIP / AGO |
Cell line / Condition | Dermal fibroblasts / 124_TD_21_a |
Location of target site | NM_014674 | 3UTR | AGGAGGAGAUUACCAGAGAAGUUGCUUUGCUCAGUGCUUUGCCCCAGGAUUGCCUCAAAUCUGAGUGGACUUCAUCCUUUGCGGCGGCUCUGAGCCUGGCCCAUCUUCCUAUUCCCACGUGUAGCUAGUGUCUA |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Accession Series | GSE161239 |
CLIP-seq Viewer | Link |
CLIP-seq Support 5 for dataset GSM4903837 | |
---|---|
Method / RBP | HITS-CLIP / AGO |
Cell line / Condition | Dermal fibroblasts / 124_TD_21_b |
Location of target site | NM_014674 | 3UTR | AGGAGGAGAUUACCAGAGAAGUUGCUUUGCUCAGUGCUUUGCCCCAGGAUUGCCUCAAAUCUGAGUGGACUUCAUCCUUUGCGGCGGCUCUGAGCCUGGCCCAUCUUCCUAUUCCCACGUGUAGCUAGUGUCUA |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Accession Series | GSE161239 |
CLIP-seq Viewer | Link |
CLIP-seq Support 6 for dataset GSM4903838 | |
---|---|
Method / RBP | HITS-CLIP / AGO |
Cell line / Condition | Dermal fibroblasts / 124_TD_21_c |
Location of target site | NM_014674 | 3UTR | UGGCUGAGGAGGAGAUUACCAGAGAAGUUGCUUUGCUCAGUGCUUUGCCCCAGGAUUGCCUCAAAUCUGAGUGGACUUCAUCCUUUGCGGCGGCUCUGAGCCUGGCCCAUCUUCCUAUUCCCACGUGUAGCUAGUGUCUA |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Accession Series | GSE161239 |
CLIP-seq Viewer | Link |
CLIP-seq Support 7 for dataset GSM714644 | |
---|---|
Method / RBP | PAR-CLIP / AGO2 |
Cell line / Condition | HEK293 / completeT1, repA |
Location of target site | ENST00000256497.4 | 3UTR | UUUGGUCAGUGCAGUUGUGCAAUCUGAGGGCCUU |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 21572407 / GSE28865 |
CLIP-seq Viewer | Link |
CLIP-seq Support 8 for dataset SRR359787 | |
---|---|
Method / RBP | PAR-CLIP / AGO2 |
Cell line / Condition | hESCs (WA-09) / 4-thiouridine, RNase T1 |
Location of target site | ENST00000256497.4 | 3UTR | UUUGGUCAGUGCAGUUGUGCAAUCUG |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 22012620 / SRX103431 |
CLIP-seq Viewer | Link |
CLIP-seq Support 9 for dataset GSM1462574 | |
---|---|
Method / RBP | PAR-CLIP / AGO2 |
Cell line / Condition | TZM-bl / TZM-bl ami BaL |
Location of target site | ENST00000256497.4 | 3UTR | UUUGGUCAGUGCAGUUGUGCAAUCUGAGGGCCU |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 23592263 / GSE59944 |
CLIP-seq Viewer | Link |
MiRNA-Target Expression Profile | |||||||
---|---|---|---|---|---|---|---|
|
MiRNA-Target Expression Profile (TCGA) | |||||||
---|---|---|---|---|---|---|---|
|
79 hsa-miR-4330 Target Genes:
Functional analysis:
ID | Target | Description | Validation methods | |||||||||
Strong evidence | Less strong evidence | |||||||||||
MIRT092330 | EDEM1 | ER degradation enhancing alpha-mannosidase like protein 1 | 2 | 6 | ||||||||
MIRT092536 | KBTBD8 | kelch repeat and BTB domain containing 8 | 2 | 6 | ||||||||
MIRT102900 | INSIG1 | insulin induced gene 1 | 2 | 6 | ||||||||
MIRT271430 | ETNK1 | ethanolamine kinase 1 | 2 | 2 | ||||||||
MIRT327637 | ZXDB | zinc finger, X-linked, duplicated B | 2 | 6 | ||||||||
MIRT441799 | BCAS1 | breast carcinoma amplified sequence 1 | 2 | 2 | ||||||||
MIRT442396 | ILDR1 | immunoglobulin like domain containing receptor 1 | 2 | 2 | ||||||||
MIRT452817 | INTS2 | integrator complex subunit 2 | 2 | 2 | ||||||||
MIRT455523 | C6orf106 | chromosome 6 open reading frame 106 | 2 | 2 | ||||||||
MIRT455885 | KIF2C | kinesin family member 2C | 2 | 2 | ||||||||
MIRT462197 | NDUFS1 | NADH:ubiquinone oxidoreductase core subunit S1 | 2 | 2 | ||||||||
MIRT462697 | SNRPD3 | small nuclear ribonucleoprotein D3 polypeptide | 2 | 2 | ||||||||
MIRT464698 | UBE2V1 | ubiquitin conjugating enzyme E2 V1 | 2 | 2 | ||||||||
MIRT465961 | TMEM189-UBE2V1 | TMEM189-UBE2V1 readthrough | 2 | 2 | ||||||||
MIRT466045 | TMEM189 | transmembrane protein 189 | 2 | 2 | ||||||||
MIRT473479 | MCFD2 | multiple coagulation factor deficiency 2 | 2 | 2 | ||||||||
MIRT473562 | MATR3 | matrin 3 | 2 | 2 | ||||||||
MIRT473945 | LYN | LYN proto-oncogene, Src family tyrosine kinase | 2 | 2 | ||||||||
MIRT475053 | JMY | junction mediating and regulatory protein, p53 cofactor | 2 | 2 | ||||||||
MIRT475532 | HOXA3 | homeobox A3 | 2 | 8 | ||||||||
MIRT475980 | GTPBP2 | GTP binding protein 2 | 2 | 2 | ||||||||
MIRT477066 | FAM208B | family with sequence similarity 208 member B | 2 | 4 | ||||||||
MIRT479327 | CERS2 | ceramide synthase 2 | 2 | 2 | ||||||||
MIRT479895 | CCDC117 | coiled-coil domain containing 117 | 2 | 2 | ||||||||
MIRT481542 | ARL5B | ADP ribosylation factor like GTPase 5B | 2 | 2 | ||||||||
MIRT482406 | ADRB1 | adrenoceptor beta 1 | 2 | 10 | ||||||||
MIRT482911 | ZNF845 | zinc finger protein 845 | 2 | 2 | ||||||||
MIRT489975 | DDB1 | damage specific DNA binding protein 1 | 2 | 2 | ||||||||
MIRT490346 | PEX10 | peroxisomal biogenesis factor 10 | 2 | 2 | ||||||||
MIRT493585 | HNRNPA1 | heterogeneous nuclear ribonucleoprotein A1 | 2 | 6 | ||||||||
MIRT496153 | RPS15A | ribosomal protein S15a | 2 | 2 | ||||||||
MIRT500620 | TXNIP | thioredoxin interacting protein | 2 | 2 | ||||||||
MIRT503158 | ANKRD11 | ankyrin repeat domain 11 | 2 | 2 | ||||||||
MIRT504479 | HSF5 | heat shock transcription factor 5 | 2 | 6 | ||||||||
MIRT504633 | MFSD8 | major facilitator superfamily domain containing 8 | 2 | 6 | ||||||||
MIRT507122 | GIGYF1 | GRB10 interacting GYF protein 1 | 2 | 6 | ||||||||
MIRT514631 | MTRNR2L7 | MT-RNR2-like 7 | 2 | 2 | ||||||||
MIRT521270 | RTN4 | reticulon 4 | 2 | 6 | ||||||||
MIRT533902 | TBL1X | transducin beta like 1X-linked | 2 | 2 | ||||||||
MIRT537583 | ESYT2 | extended synaptotagmin 2 | 2 | 2 | ||||||||
MIRT540430 | FAM83F | family with sequence similarity 83 member F | 2 | 2 | ||||||||
MIRT544324 | TMEM81 | transmembrane protein 81 | 2 | 4 | ||||||||
MIRT548303 | EPHA7 | EPH receptor A7 | 2 | 2 | ||||||||
MIRT552766 | YIPF6 | Yip1 domain family member 6 | 2 | 2 | ||||||||
MIRT555669 | PGAM4 | phosphoglycerate mutase family member 4 | 2 | 2 | ||||||||
MIRT561279 | ZCCHC3 | zinc finger CCHC-type containing 3 | 2 | 2 | ||||||||
MIRT564575 | ZXDA | zinc finger, X-linked, duplicated A | 2 | 2 | ||||||||
MIRT565812 | SDCCAG3 | serologically defined colon cancer antigen 3 | 2 | 2 | ||||||||
MIRT568741 | MTRNR2L1 | MT-RNR2-like 1 | 2 | 2 | ||||||||
MIRT569363 | PRMT6 | protein arginine methyltransferase 6 | 2 | 2 | ||||||||
MIRT570608 | MTRNR2L11 | MT-RNR2-like 11 | 2 | 2 | ||||||||
MIRT572424 | PTGES3L | prostaglandin E synthase 3 like | 2 | 2 | ||||||||
MIRT576542 | Txlna | taxilin alpha | 2 | 2 | ||||||||
MIRT610568 | HIST3H2BB | histone cluster 3 H2B family member b | 2 | 2 | ||||||||
MIRT617497 | IFT46 | intraflagellar transport 46 | 2 | 2 | ||||||||
MIRT617773 | C17orf105 | chromosome 17 open reading frame 105 | 2 | 2 | ||||||||
MIRT619275 | CEP57L1 | centrosomal protein 57 like 1 | 2 | 2 | ||||||||
MIRT624618 | ATXN7L3B | ataxin 7 like 3B | 2 | 2 | ||||||||
MIRT628001 | MELK | maternal embryonic leucine zipper kinase | 2 | 2 | ||||||||
MIRT646325 | MVB12B | multivesicular body subunit 12B | 2 | 2 | ||||||||
MIRT648697 | TNFRSF13C | TNF receptor superfamily member 13C | 2 | 2 | ||||||||
MIRT665675 | TOR1B | torsin family 1 member B | 2 | 2 | ||||||||
MIRT669730 | ZBTB8B | zinc finger and BTB domain containing 8B | 2 | 2 | ||||||||
MIRT676242 | PARP2 | poly(ADP-ribose) polymerase 2 | 2 | 2 | ||||||||
MIRT683205 | MBNL1 | muscleblind like splicing regulator 1 | 2 | 2 | ||||||||
MIRT684425 | TUFT1 | tuftelin 1 | 2 | 2 | ||||||||
MIRT688864 | CAMKK2 | calcium/calmodulin dependent protein kinase kinase 2 | 2 | 2 | ||||||||
MIRT693406 | NUDT16 | nudix hydrolase 16 | 2 | 2 | ||||||||
MIRT694597 | AAR2 | AAR2 splicing factor homolog | 2 | 2 | ||||||||
MIRT698399 | TMED10 | transmembrane p24 trafficking protein 10 | 2 | 2 | ||||||||
MIRT698435 | TM4SF1 | transmembrane 4 L six family member 1 | 2 | 2 | ||||||||
MIRT708290 | ZNF24 | zinc finger protein 24 | 2 | 2 | ||||||||
MIRT709766 | GPR183 | G protein-coupled receptor 183 | 2 | 2 | ||||||||
MIRT710713 | KRTAP6-1 | keratin associated protein 6-1 | 2 | 2 | ||||||||
MIRT711643 | LIPG | lipase G, endothelial type | 2 | 2 | ||||||||
MIRT713246 | SLC22A3 | solute carrier family 22 member 3 | 2 | 2 | ||||||||
MIRT714008 | IL6R | interleukin 6 receptor | 2 | 2 | ||||||||
MIRT721851 | C1QTNF3 | C1q and TNF related 3 | 2 | 2 | ||||||||
MIRT724003 | TMEM174 | transmembrane protein 174 | 2 | 2 |
miRNA-Drug Associations | ||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
miRNA-Drug Resistance Associations | ||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|